AbbVie raised its 2025 profit forecast on Thursday, after beating Wall Street estimates for second-quarter results on strong ...

ServiceNow, Inc. (NYSE:NOW) is one of the AI Stocks in the Spotlight Today. On July 28, Cantor Fitzgerald analyst Thomas ...

According to TipRanks, UBS, Cowen, and BTIG Research have all reiterated buy ratings in the last couple of months. HC ...

Snowflake Inc. (NYSE:SNOW) ranks among the best magic formula stocks to invest in. Cantor Fitzgerald reaffirmed its ...

In addition to Cantor Fitzgerald, Merck & Company also received a Hold from Wells Fargo’s Mohit Bansal in a report issued today. However, on the same day, TR | OpenAI – 4o reiterated a Buy rating on ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

Fintel reports that on July 30, 2025, Cantor Fitzgerald upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Neutral to Overweight. Analyst Price Forecast Suggests 206.26% Upside As of July ...

Fintel reports that on July 28, 2025, Cantor Fitzgerald downgraded their outlook for Centene (NYSE:CNC) from Overweight to ...

In a lengthy report, federal government officials set out a roadmap for delivering on President Donald Trump’s promise to ...

Cantor Fitzgerald LP affiliates Newmark Group Inc. and BGC Group Inc. are suing to seize equity from a commercial real estate ...

Replimune (NASDAQ:REPL) stock surges as Cantor Fitzgerald upgrades, citing improved odds for approval of its lead drug after an FDA leadership change. Read more here.

A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals suggested big pharma may finally be willing to place ...